Effects of serelaxin in patients with acute heart failure (2019)
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: DOENÇA AGUDA, DOENÇAS CARDIOVASCULARES, INSUFICIÊNCIA CARDÍACA, PROTEÍNAS RECOMBINANTES, FÁRMACOS (SISTEMA CARDIOVASCULAR)
ABNT
METRA, M. et al. Effects of serelaxin in patients with acute heart failure. The New England Journal of Medicine, v. 381, n. 8, p. 716-726, 2019Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa180129. Acesso em: 09 maio 2024.APA
Metra, M., Teerlink, J. R., Cotter, G., Davison, B. A., Felker, G. M., Filippatos, G., et al. (2019). Effects of serelaxin in patients with acute heart failure. The New England Journal of Medicine, 381( 8), 716-726. doi:10.1056/NEJMoa180129NLM
Metra M, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Simões MV. Effects of serelaxin in patients with acute heart failure [Internet]. The New England Journal of Medicine. 2019 ; 381( 8): 716-726.[citado 2024 maio 09 ] Available from: https://doi.org/10.1056/NEJMoa180129Vancouver
Metra M, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Simões MV. Effects of serelaxin in patients with acute heart failure [Internet]. The New England Journal of Medicine. 2019 ; 381( 8): 716-726.[citado 2024 maio 09 ] Available from: https://doi.org/10.1056/NEJMoa180129